New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome

Key facts

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Principal Investigator

Lynnette K Nieman, M.D., M.D

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Intervention

Pentetreotide(drug)

Enrollment

95 enrolled

Eligibility

18-90 years · All sexes

Timeline

1999 – 2019

Study locations (1)

• National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Adrenal Cushing syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07168122
  Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
  Shanghai 6th People's Hospital
• RECRUITINGNANCT06250699
  A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
  Zhe Meng
• RECRUITINGNANCT05911620
  Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism
  Central Hospital, Nancy, France
• RECRUITINGNANCT05881005
  NAC- NAFLD and Cushing
  University Hospital, Angers
• RECRUITINGNCT06050057
  Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
  University Hospital Olomouc
• RECRUITINGNCT05521529
  Cushing's Syndrome Before and After Treatment (CORRECT)
  University of Aarhus
• ACTIVE NOT RECRUITINGNCT05446779
  Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death
  Helsinki University Central Hospital
• RECRUITINGPHASE2NCT03708900
  Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
  RECORDATI GROUP

See all trials for Adrenal Cushing syndrome →